Financhill
Buy
63

BSX Quote, Financials, Valuation and Earnings

Last price:
$88.82
Seasonality move :
11.56%
Day range:
$87.25 - $89.67
52-week range:
$55.60 - $91.93
Dividend yield:
0%
P/E ratio:
73.51x
P/S ratio:
8.29x
P/B ratio:
6.33x
Volume:
15.7M
Avg. volume:
5.3M
1-year change:
61.79%
Market cap:
$131.1B
Revenue:
$14.2B
EPS (TTM):
$1.21

BSX Analysts' Consensus Rating

The 25 analysts providing 12-month price projections for Boston Scientific shares anticipate an average target of $99.00, ranging from a low estimate of $83.00 to a high estimate of $116.00. This average target implies a growth of 11.3% compared to the current stock price of $88.95.

Consensus Price Target

$99.00

Highest Price Target

$116.00

Lowest Price Target

$83.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 21 20 20

Hold 3 5 5

Sell 0 0 0
Consensus Buy Buy Buy

BSX Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is down 1.82% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 1.43% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 6.46% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock